Compare Abeona Therapeutics Inc (ABEO) vs Manhattan Associates Inc (MANH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Manhattan Associates Inc — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while Manhattan Associates Inc trades at $189.84 (market cap $11.38B). The key difference: Manhattan Associates Inc is far larger — about 27× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Manhattan Associates Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | MANH | |
|---|---|---|
Market Cap | $421.19M | $11.38B |
Sector | Health | Technology |
52-Week High | $7.45 | $220.19 |
52-Week Low | $4.17 | $120.88 |
Enterprise Value | $276.10M | $11.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →
